Omentin-1 levels in patients with premature coronary artery disease, metabolic syndrome and healthy controls. Short communication

Biomedical Papers

Volumn 160, Issue 2, 2016, Pages 219-221

  Stejskal, David ^a,b,c   Vaclavik, Jan ^d   Smekal, Ales ^d   Svobodova, Gabriela ^a,b   Richterova, Radmila ^e   Svestak, Marek ^a,b  

^a Agel Research and Training Institute CGB Laboratory Ostrava Vitkovice Branch   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF OSTRAVA   (Czech Republic)

^d UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^e AGEL Laboratory Department of Molecular Biology Genetics laboratory   (Czech Republic)

Author keywords

Acute myocardial infarction; Adipokines; Coronary artery disease; ELISA; Omentin 1; Premature manifestation

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADOLESCENT; ADULT; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GPI-LINKED PROTEINS; HUMANS; LECTINS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; REPRODUCIBILITY OF RESULTS; ROC CURVE; YOUNG ADULT;

EID: 84976402711     PISSN: 12138118     EISSN: 18047521     Source Type: Journal    
DOI: 10.5507/bp.2016.019     Document Type: Article

References (15)

1. Schäffler A, Neumeier M, Herfarth H, Fürst A, Schölmerich J, Büchler C: Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochemica et Biophysica acta 2005;1732:96-102.
2. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC, and Gong DW: Identification of omentin as a novel depot-specific adipokine in Human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006;290:E1253-E1261.
3. Kocijancic M, Vujicic B, Racki S, Cubranic Z, Zaputovic L, Dvornik S. Serum omentin-1 levels as a possible risk factor of mortality in patients with diabetes on haemodialysis. Diabetes Res Clin Pract 2015;110(1):44-50. doi: 10.1016/j.diabres.2015.06.008
4. Onur I, Oz F, Yildiz S, Kuplay H, Yucel C, Sigirci S, Elitok A, Pilten S, Kasali K, Yasar Cizgici A, Erentug V, Dinckal HM. A decreased serum omentin-1 level may be an independent risk factor for peripheral arterial disease. Int Angiol 2014;33:455-6.
5. Yin J, Hou P, Wu Z, Nie Y. Decreased levels of serum omentin-1 in patients with inflammatory bowel disease. Med Sci Monit 2015;21:118-22. doi: 10.12659/MSM.892081
6. Garcés MF, Ruíz-Linares CE, Vallejo SA, et al. Maternal serum omentin-1 profile is similar in humans and in the rat animal model. Cytokine 2015;75(1):136-41. doi: 10.1016/j.cyto.2015.06.014
7. Onur I, Oz F, Yildiz S, Oflaz H, Sigirci S, Elitok A, Pilten S, Karaayvaz EB, Cizgici AY, Kaya MG, Onur ST, Sahin I, Dinckal HM. Serum omentin 1 level is associated with coronary artery disease and its severity in postmenopausal women. Angiology 2014;65(10):896-900.
8. Shibata R, Ouchi N, Kikuchi R, Takahashi R, Takeshita K, Kataoka Y, Ohashi K, Ikeda N, Kihara S, Murohara T. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 2011;219(2):811-4.
9. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Circulation 2009;120(16):1640-5.
10. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD et al. and ESC Committee for Practice Guidelines. Third universal definition of myocardial infarction. Eur Heart J 2012;33(20):2551-67.
11. Shang FJ, Wang JP, Liu XT, Zheng QS, Xue YS, Wang B, Zhao LY. Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome. Biomarkers 2011;16(8):657-62.
12. Kodoglou NP, Tahmatzidis DK, Giannakoulas C, Kapelouzou A, Gkontopoulos A, Parissis J, Lampropoulos S, Kottas G. Serum levels of novel adipokines, omentin-1 and chemerin, in patients with acute myocardial infarction: KOZANI STUDY. J Cardiovasc Med (Hagerstown) 2015;16:341-6.
13. Wittenbecher C, di Giuseppe R, Biemann R, Menzel J, Arregui M, Hoffmann J, Aleksandrova K, Boeing H, Isermann B, Schulze MB, Weikert C. Reproducibility of Retinol Binding Protein 4 and Omentin-1 Measurements over a Four Months Period: A Reliability Study in a Cohort of 207 Apparently Healthy Participants. PLoS One 2015;10:e0138480.
14. De Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, Fried SK, Gong DW, Shuldiner AR, Pollin TI, and McLenithan JC: Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007; 56:1655-61.
15. Wilms B, Ernst B, Gerig R, Schultes B. Plasma omentin-1 levels are related to exercise performance in obese women and increase upon aerobic endurance training. Exp Clin Endocrinol Diabetes 2015;123(3):187-92.